Together, we cure Duchenne
CureDuchenne (cureduchenne.org) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Non-profit brands, Healthcare brands, in the 71st percentile of 13683 Non-profit brands.
CureDuchenne is a nonprofit organization based in Newport Beach, United States, founded in 2004 with the mission to cure Duchenne muscular dystrophy (DMD). It uses a venture philanthropy model to fund research, early diagnosis, and treatment development, aiming to accelerate promising scientific projects into clinical trials. The organization also provides direct support services to families and patients affected by DMD, serving researchers, clinicians, and donors interested in advancing treatments and a cure.
| Brand Name | CureDuchenne |
|---|---|
| Domain | cureduchenne.org |
| Industry | Non-profit, Healthcare |
| Founded | 2004 |
| Headquarters | Newport Beach, United States |
| Main Competitors | Muscular Dystrophy Association (84/100), Parent Project Muscular Dystrophy (77/100), Jett Foundation (62/100), Charley's Fund (76/100), Duchenne UK |
Moz Domain Authority 54/100 vs category average 50 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,235,105 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "CureDuchenne’s mission - cure Duchenne muscular dystrophy (DMD). Our venture philanthropy model funds research, early diagnosis, treatment" (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is CureDuchenne?", Claude could identify the brand as of October 2026. CureDuchenne is a nonprofit organization founded in 2003 that funds research into treatments and a cure for Duchenne muscular dystrophy, a rare genetic muscle-wasting disease. It funds scientific research, supports gene therapy and exon-skipping treatment development, and provide Best known for Funding and accelerating research for Duchenne muscular dystrophy treatments, including gene therapy approaches.
When asked "Best brands similar to CureDuchenne?", Claude would recommend CureDuchenne as of October 2026. It's one of the most established and respected nonprofits specifically focused on Duchenne muscular dystrophy research and family support.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CureDuchenne's main competitors in Non-profit: Muscular Dystrophy Association (84/100), Parent Project Muscular Dystrophy (77/100), Jett Foundation (62/100), Charley's Fund (76/100).
Sources: Brand Analyzer scan
CureDuchenne is a nonprofit organization headquartered in Newport Beach, United States, founded in 2004. Its mission is to cure Duchenne muscular dystrophy (DMD) through research, early diagnosis, and treatment. It is classified under the Non-profit and Healthcare categories.
Sources: CureDuchenne official site
CureDuchenne has limited AI-search visibility, scoring 41/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 61, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CureDuchenne official site
CureDuchenne was founded in 2004. CureDuchenne operates in the Non-profit category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
CureDuchenne funds scientific research, early diagnosis initiatives, and treatment development for Duchenne muscular dystrophy using a venture philanthropy model. This approach is designed to accelerate promising research projects into clinical trials. The organization also provides direct support services to families and patients living with DMD.
Sources: CureDuchenne official site
CureDuchenne scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Non-profit options. Recommendation depends on crawlability, structured data, and category authority.
Sources: CureDuchenne official site
CureDuchenne offers funding for research into Duchenne muscular dystrophy, support for early diagnosis efforts, and programs aimed at advancing treatments toward clinical trials. It also provides direct support services for families and patients affected by DMD.
Sources: CureDuchenne official site
CureDuchenne can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CureDuchenne official site
CureDuchenne's work is used by families and patients affected by Duchenne muscular dystrophy, as well as researchers and clinicians working on treatments, and donors who support the organization's funding efforts.
Sources: CureDuchenne official site
CureDuchenne is known for its venture philanthropy model, which funds and accelerates research and treatment projects for Duchenne muscular dystrophy, moving them toward clinical trials, while also offering family support services.
Sources: CureDuchenne official site
CureDuchenne scores 41/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CureDuchenne has a limited AI-visibility profile at 41/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (61/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,235,105 (Tranco) and a Moz Domain Authority of 54/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify CureDuchenne from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CureDuchenne: Concordia University, Nebraska (80/100), Cultural Vistas (80/100), CURE Epilepsy (80/100), Institut Curie (80/100).
A step up - brands to learn from: Zero Project (81/100), Youth Villages (81/100).
Category leader: Change.org (97/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.